DK113641B - Fremgangsmåde til fremstilling af steroidketoner. - Google Patents

Fremgangsmåde til fremstilling af steroidketoner.

Info

Publication number
DK113641B
DK113641B DK448162AA DK448162A DK113641B DK 113641 B DK113641 B DK 113641B DK 448162A A DK448162A A DK 448162AA DK 448162 A DK448162 A DK 448162A DK 113641 B DK113641 B DK 113641B
Authority
DK
Denmark
Prior art keywords
production
steroid ketones
steroid
ketones
Prior art date
Application number
DK448162AA
Other languages
English (en)
Inventor
G Hughes
H Smith
Original Assignee
H Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE651797D priority Critical patent/BE651797A/xx
Application filed by H Smith filed Critical H Smith
Priority to GB4001667A priority patent/GB1100443A/en
Priority to GB4001767A priority patent/GB1100444A/en
Priority to IL2182664A priority patent/IL21826A/en
Priority to NO15427664A priority patent/NO126016B/no
Priority to IN95058A priority patent/IN95058B/en
Priority to DE19641618871 priority patent/DE1618871C3/de
Priority to DE19641793641 priority patent/DE1793641C2/de
Priority to DE19641618872 priority patent/DE1618872C3/de
Priority to BR16164364A priority patent/BR6461643D0/pt
Priority to DE19641468988 priority patent/DE1468988B1/de
Priority to CH1742068A priority patent/CH498820A/de
Priority to CH1742168A priority patent/CH498821A/de
Priority to CH1052964A priority patent/CH498819A/de
Priority to CH381370A priority patent/CH499510A/de
Priority to CH1387870A priority patent/CH507225A/de
Priority to FR1566154D priority patent/FR1566154A/fr
Priority to DK400464A priority patent/DK134161B/da
Priority to AT696964A priority patent/AT269376B/de
Priority to AT227470A priority patent/AT301045B/de
Priority to AT292768A priority patent/AT301039B/de
Priority to NL6409391A priority patent/NL139307B/xx
Priority to SE843170A priority patent/SE350256B/xx
Priority to SE983464A priority patent/SE331470B/xx
Priority to FR994684A priority patent/FR4915M/fr
Priority to NO16575366A priority patent/NO127193B/no
Priority to NO16575266A priority patent/NO132762C/no
Priority to SE04239/68A priority patent/SE334879B/xx
Priority to SE04237/68A priority patent/SE335119B/xx
Priority to SE04238/68A priority patent/SE335120B/xx
Publication of DK113641B publication Critical patent/DK113641B/da
Priority to DK655269A priority patent/DK127598B/da
Priority to JP5758471A priority patent/JPS4837029B1/ja
Priority to DK395771A priority patent/DK132031C/da
Priority to NO495971A priority patent/NO129905B/no
Priority to DK220272A priority patent/DK127475B/da
Priority to DK38273A priority patent/DK131020B/da
Priority to DK84773A priority patent/DK131367B/da
Priority to DK286173A priority patent/DK134264B/da
Priority to NL7308508A priority patent/NL7308508A/xx
Priority to NL737308507A priority patent/NL145559B/xx
Priority to IN1001/CAL/74A priority patent/IN137557B/en
Priority to IN137555A priority patent/IN137555B/en
Priority to IN1000/CAL/74A priority patent/IN137556B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B3/00—Footwear characterised by the shape or the use
    • A43B3/12—Sandals; Strap guides thereon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Woven Fabrics (AREA)
  • Manufacturing Of Printed Wiring (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
DK448162AA 1961-10-19 1962-10-17 Fremgangsmåde til fremstilling af steroidketoner. DK113641B (da)

Priority Applications (43)

Application Number Priority Date Filing Date Title
BE651797D BE651797A (da) 1962-10-17
GB4001667A GB1100443A (en) 1962-10-17 1963-08-14 17ª‡-chloroethynyl-13ª‰-ethylgonenolone
GB4001767A GB1100444A (en) 1962-10-17 1963-08-14 13-alkyl 17-halogenoalkynyl steroid 3-alcohols and their esters
IL2182664A IL21826A (en) 1962-10-17 1964-08-03 Steroid ketones and their derivatives
NO15427664A NO126016B (da) 1962-10-17 1964-08-05
IN95058A IN95058B (da) 1962-10-17 1964-08-05
BR16164364A BR6461643D0 (pt) 1962-10-17 1964-08-10 Processo de preparacao de cetonas esteroides e seus derivados
DE19641793641 DE1793641C2 (de) 1962-10-17 1964-08-10 Verfahren zur Herstellung von 17-Halogenalkinyl 3-ketogonen und deren Verwendung. Ausscheidung aus: 1468988
DE19641618872 DE1618872C3 (de) 1962-10-17 1964-08-10 Verfahren zur Herstellung von 13-Äthylgonanverbindungen und gewisse 13-Äthylgonanverbindungen. Ausscheidung aus: 1468988
DE19641618871 DE1618871C3 (de) 1962-10-17 1964-08-10 Verfahren zur Herstellung eines Steroidketonderivates. Ausscheidung aus: 1468988
DE19641468988 DE1468988B1 (de) 1962-10-17 1964-08-10 17alpha-Chloraethinyl-13beta-aethyl-4- oder -5(10)-gonen-3-ketone
CH1052964A CH498819A (de) 1962-10-17 1964-08-12 Verfahren zur Herstellung von Steroidketonen mit 17- oder 17a-Halogenalkinylgruppen
CH1742168A CH498821A (de) 1962-10-17 1964-08-12 Verfahren zur Herstellung von Steroidketonderivaten mit 17- und 17a-Halogenalkinylgruppen
CH1742068A CH498820A (de) 1961-10-19 1964-08-12 Verfahren zur Herstellung von Steroidketonderivaten mit 17- oder 17a-Halogenalkinylgruppen
CH381370A CH499510A (de) 1962-10-17 1964-08-12 Verfahren zur Herstellung von Steroidketonderivaten mit 17-oder 17a-Halogenalkinylgruppen
CH1387870A CH507225A (de) 1962-10-17 1964-08-12 Verfahren zur Herstellung von Steroidketonen mit 17- oder 17a-Halogenalkinylgruppen
FR1566154D FR1566154A (da) 1962-10-17 1964-08-13
DK400464A DK134161B (da) 1962-10-17 1964-08-13 Analogifremgangsmåde til fremstilling af steroidketoner.
AT696964A AT269376B (de) 1962-10-17 1964-08-13 Verfahren zur Herstellung von neuen Steroidketonen
AT227470A AT301045B (de) 1962-10-17 1964-08-13 Verfahren zur Herstellung von neuen Steroiden
AT292768A AT301039B (de) 1962-10-17 1964-08-13 Verfahren zur Herstellung von neuen Steroiden
NL6409391A NL139307B (nl) 1962-10-17 1964-08-14 Werkwijze voor het bereiden van een geneesmiddel met een hormoonactiviteit.
SE983464A SE331470B (da) 1962-10-17 1964-08-14
SE843170A SE350256B (da) 1962-10-17 1964-08-14
FR994684A FR4915M (da) 1962-10-17 1964-11-12
NO16575366A NO127193B (da) 1962-10-17 1966-11-25
NO16575266A NO132762C (da) 1962-10-17 1966-11-25
SE04239/68A SE334879B (da) 1962-10-17 1968-03-29
SE04237/68A SE335119B (da) 1962-10-17 1968-03-29
SE04238/68A SE335120B (da) 1962-10-17 1968-03-29
DK655269A DK127598B (da) 1962-10-17 1969-12-10 Analogifremgangsmåde til fremstilling af 17-halogenalkynyl-3,17-dihydroxy-13-ethylgonener eller -D-homogener eller estere eller ethere deraf.
JP5758471A JPS4837029B1 (da) 1962-10-17 1971-08-02
DK395771A DK132031C (da) 1962-10-17 1971-08-12 Analogifremgangsmade til fremstilling af 17-haloalkynyl-17-hydroxy-13-ethyl-gonen-3-oner eller de tilsvarende d-homo-forbindelser
NO495971A NO129905B (da) 1962-10-17 1971-12-30
DK220272A DK127475B (da) 1962-10-17 1972-05-03 Analogifremgangsmåde til fremstilling af17-halogenalkynyl-17-hydroxy-13-ethylgonener eller -D-homogonener eller estere eller ethere deraf.
DK38273A DK131020B (da) 1962-10-17 1973-01-24 Antikonceptionelt middel.
DK84773A DK131367B (da) 1962-10-17 1973-02-16 Antikonceptionelt middel.
DK286173A DK134264B (da) 1962-10-17 1973-05-24 Antikonceptionelt middel.
NL7308508A NL7308508A (da) 1962-10-17 1973-06-19
NL737308507A NL145559B (nl) 1962-10-17 1973-06-19 Werkwijze voor het bereiden van een preparaat met progestatieve en anti-oestrogene activiteit, gevormd geneesmiddel en werkwijze voor het bereiden van progestatieve en anti-oestrogeen actieve verbindingen.
IN1001/CAL/74A IN137557B (da) 1962-10-17 1974-05-03
IN137555A IN137555B (da) 1962-10-17 1974-05-03
IN1000/CAL/74A IN137556B (da) 1962-10-17 1974-05-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB37618/61A GB1041279A (en) 1961-10-19 1961-10-19 13-alkyl steroid ketones

Publications (1)

Publication Number Publication Date
DK113641B true DK113641B (da) 1969-04-14

Family

ID=10397775

Family Applications (6)

Application Number Title Priority Date Filing Date
DK448162AA DK113641B (da) 1961-10-19 1962-10-17 Fremgangsmåde til fremstilling af steroidketoner.
DK449562AA DK121228B (da) 1961-10-19 1962-10-18 Analogifremgangsmåde til fremstilling af umættede steroidketoner.
DK449662AA DK115549B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.
DK449762AA DK115621B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.
DK227069AA DK129652B (da) 1961-10-19 1969-04-24 17-Carbonhydrid-substituerede 3,17-dihydroxy-13-alkyl-gonener til anvendelse som mellemprodukter ved fremstilling af farmakologisk aktive, tilsvarende 17-carbonhydrid-substituerede 3-oxo-17-hydroxy-13-alkyl-gon-4- eller -5(10)-ener.
DK339670AA DK124753B (da) 1961-10-19 1970-06-30 Analogifremgangsmåde til fremstilling af 13-alkyl-gonen-3,17-dioler.

Family Applications After (5)

Application Number Title Priority Date Filing Date
DK449562AA DK121228B (da) 1961-10-19 1962-10-18 Analogifremgangsmåde til fremstilling af umættede steroidketoner.
DK449662AA DK115549B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.
DK449762AA DK115621B (da) 1961-10-19 1962-10-18 Fremgangsmåde til fremstilling af umættede steroidketoner.
DK227069AA DK129652B (da) 1961-10-19 1969-04-24 17-Carbonhydrid-substituerede 3,17-dihydroxy-13-alkyl-gonener til anvendelse som mellemprodukter ved fremstilling af farmakologisk aktive, tilsvarende 17-carbonhydrid-substituerede 3-oxo-17-hydroxy-13-alkyl-gon-4- eller -5(10)-ener.
DK339670AA DK124753B (da) 1961-10-19 1970-06-30 Analogifremgangsmåde til fremstilling af 13-alkyl-gonen-3,17-dioler.

Country Status (12)

Country Link
AT (4) AT264730B (da)
CH (5) CH450407A (da)
CY (1) CY429A (da)
DE (4) DE1468604C2 (da)
DK (6) DK113641B (da)
ES (1) ES281669A1 (da)
FI (4) FI41026B (da)
FR (1) FR2796M (da)
GB (2) GB1041279A (da)
MY (1) MY6800075A (da)
NO (4) NO122643B (da)
SE (6) SE312552B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2636404C2 (de) * 1976-08-12 1983-12-08 Schering AG, 1000 Berlin und 4709 Bergkamen Δ↑1↑↑5↑-17α-Äthinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
CN104926906B (zh) * 2015-06-04 2016-02-10 保定北瑞甾体生物有限公司 一种17α-羟基黄体酮的制备方法

Also Published As

Publication number Publication date
AT256354B (de) 1967-08-25
DE1793608B1 (de) 1972-05-04
FR2796M (fr) 1964-09-21
NO122645B (da) 1971-07-26
SE312552B (da) 1969-07-21
DE1617818B2 (de) 1976-12-09
NO122643B (da) 1971-07-26
DE1468604B1 (de) 1970-07-02
SE313809B (da) 1969-08-25
CH455763A (de) 1968-05-15
SE312551B (da) 1969-07-21
AT256356B (de) 1967-08-25
AT264730B (de) 1968-09-10
GB1041279A (en) 1966-09-01
FI41024B (da) 1969-04-30
AT256355B (de) 1967-08-25
NO122646B (da) 1971-07-26
DK129652C (da) 1975-04-07
DK124753B (da) 1972-11-20
DE1793595B2 (de) 1975-10-30
CH459195A (de) 1968-07-15
DE1618855B2 (de) 1973-04-05
CH450408A (de) 1968-01-31
CH432509A (de) 1967-03-31
SE340619B (da) 1971-11-29
SE312553B (da) 1969-07-21
DK115621B (da) 1969-10-27
CH450407A (de) 1968-01-31
FI41025B (da) 1969-04-30
MY6800075A (en) 1968-12-31
DK115549B (da) 1969-10-20
DE1617818A1 (de) 1972-05-18
CY429A (en) 1968-01-15
DE1468604C2 (de) 1971-03-04
SE335526B (da) 1971-06-01
DE1618855C3 (da) 1973-10-25
DK121228B (da) 1971-09-27
FI41026B (da) 1969-04-30
DK129652B (da) 1974-11-04
ES281669A1 (es) 1963-03-16
FI41027B (da) 1969-04-30
NO122644B (da) 1971-07-26
GB1041278A (en) 1966-09-01
DE1793595A1 (de) 1972-02-03
DE1618855A1 (de) 1972-05-18

Similar Documents

Publication Publication Date Title
DK104168C (da) Fremgangsmåde til fremstilling af mono-biguanider.
DK118242B (da) Fremgangsmåde til fremstilling af anhydropenicilliner.
DK108976C (da) Fremgangsmåde til fremstilling af hendecapeptider.
DK108455C (da) Fremgangsmåde til fremstilling af i 5-stillingen usubstituerede 2-amino-benzophenoner.
DK107027C (da) Fremgangsmåde til fremstilling af 3-hydroxy-benzisoxazoler.
DK113641B (da) Fremgangsmåde til fremstilling af steroidketoner.
DK134161B (da) Analogifremgangsmåde til fremstilling af steroidketoner.
DK106184C (da) Fremgangsmåde til fremstilling af alkylaralkylftalater.
DK118082B (da) Fremgangsmåde til fremstilling af 4-cyanthiazol.
DK111322B (da) Fremgangsmåde til fremstilling af DL-ribose.
DK108188C (da) Fremgangsmåde til fremstilling af trichlorethylen.
DK104055C (da) Fremgangsmåde til fremstilling af 6-methoxytetraloner.
DK104136C (da) Fremgangsmåde til fremstilling af benzensulfonylsemicarbazider.
DK104347C (da) Fremgangsmåde til fremstilling af 16α-hydroxysteroider.
DK104730C (da) Fremgangsmåde til fremstilling af 3-N-subtituerede cyclohexenonderivater.
DK105152C (da) Fremgangsmåde til fremstilling af L-methionin.
DK99050C (da) Fremgangsmåde til fremstilling af uranium-aluminiumlegeringer.
DK105270C (da) Fremgangsmåde til fremstilling af betamethason.
DK102292C (da) Fremgangsmåde til fremstilling af 17α-hydroxy-20-keto-16β-methyl-steroider.
DK104625C (da) Fremgangsmåde til fremstilling af estrogener.
DK94989C (da) Fremgangsmåde til fremstilling af umættede ketoner.
DK88967C (da) Fremgangsmåde til fremstilling af umættede ketoner.
DK109693C (da) Fremgangsmåde til fremstilling af ω-lactamer.
DK98560C (da) Fremgangsmåde til fremstilling af 2-chlor-4-azaphenthiazin.
DK103126C (da) Fremgangsmåde til fremstilling af 2-β-metoksyætylpyridin.